• Subcutaneously administered monoclonal antibodies associated with reduced hospitalization and death amongst COVID 19 outpatients

    1 month ago - By News Medical

    A new preprint describes the results of a study that compares intravenous administration of one such therapy to its subcutaneous use, in terms of clinical outcomes.
    Read more ...

     

  • Vaccinate Children With Poorly Controlled Asthma to Cut COVID-19 Risk

    Vaccinate Children With Poorly Controlled Asthma to Cut COVID-19 Risk

    1 month ago - By Medindia Health

    Experts advise that 5- to 17-year-old children with poorly controlled asthma should be considered for vaccination to reduce the risk of infection and the spread of COVID-19 in schools and households.
    Read more ...

     

  • More regions of Russia require vaccines for people 60 and up

    1 month ago - By ABC News

    More regions of Russia have made COVID-19 vaccines mandatory for residents age 60 and over as the country tries to control coronavirus infections and to keep the omicron variant at bay
    Read more ...

     

  • Are COVID-19 Vaccine Boosters Safe and Increase Immunity?

    Are COVID-19 Vaccine Boosters Safe and Increase Immunity?

    1 month ago - By Medindia Health

    The randomized, phase 2 trial of COVID-19 booster vaccines find seven increased immunity when given 10-12 weeks after two doses of Oxford-AstraZeneca, and six increased immunity following two doses of Pfizer-BioNTech.
    Read more ...

     

  • First Malaria Vaccine a Major Milestone Despite Hurdles Ahead

    1 month ago - By Medscape

    The four-dose vaccine, advanced by landmark COVID-19 prevention efforts, is an achievement that scientists have been painstakingly working toward for decades.
    WebMD Health News
    Read more ...

     

  • Dupilumab treatment for atopic dermatitis may mitigate COVID-19 symptoms

    Dupilumab treatment for atopic dermatitis may mitigate COVID-19 symptoms

    1 month ago - By Healio

    Patients taking dupilumab for atopic dermatitis experienced less severe COVID-19 symptoms than patients who used different or no treatment, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
    “At the beginning of the pandemic, we started to notice that many patients who you would think would have risk factors for more severe infections had very minor manifestations,” Emma Guttman-Yassky, MD, PhD, the Sol and Clara Kest professor and vice chair for research in the department of dermatology and laboratory of inflammatory skin diseases at
    Read more ...

     

  • Study: Black, Asian Britons have higher COVID-19 death rates

    1 month ago - By ABC News

    A British study has found that Black and other ethnic minority people in the U
    Read more ...

     

  • Study finds third dose of BNT162b2 or mRNA-1273 is moderately effective against post-vaccination COVID-19 infection

    1 month ago - By News Medical

    The current study used VHA electronic health records to estimate the effectiveness of the booster dose in the USA against post-vaccination COVID-19.
    Read more ...